cyclohexanol has been researched along with Age-Related Memory Disorders in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ganea, D; Myers, AM; Ronca, RD; Tuma, RF; Walker, EA; Ward, SJ | 1 |
Lichtman, AH; Thorpe, AJ; Wise, LE | 1 |
Buzsáki, G; Robbe, D | 1 |
Bini, V; Borcel, E; Castelli, MP; Llorente, R; Loriga, R; Luesu, W; Mateos, B; Viveros, MP | 1 |
Dai, MH; Han, Y; Li, DQ | 1 |
Mallet, PE; McGregor, IS; O'Shea, M; Singh, ME | 1 |
Mulsant, BH | 1 |
Aparicio Jabalquinto, G; Barriochoa Martínez de Pisón, C; Ortega García, A; Raigal Martín, Y; Sierra Santos, L | 1 |
Braida, D; Sala, M | 1 |
1 review(s) available for cyclohexanol and Age-Related Memory Disorders
Article | Year |
---|---|
[Venlafaxine and its discontinuation syndrome].
Topics: Adult; Antidepressive Agents, Second-Generation; Attention; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Memory Disorders; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride; Visual Acuity | 1999 |
8 other study(ies) available for cyclohexanol and Age-Related Memory Disorders
Article | Year |
---|---|
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice.
Topics: Animals; Anisoles; Cannabinoid Receptor Agonists; Cerebral Infarction; Conditioning, Operant; Cyclohexanols; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Psychomotor Performance; Receptor, Cannabinoid, CB2; Recognition, Psychology; Stroke | 2015 |
Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
Topics: Analysis of Variance; Animals; Catheterization; Central Nervous System Agents; Cyclohexanols; Dronabinol; Hippocampus; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Microinjections; Piperidines; Psychotropic Drugs; Pyrazoles; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant | 2009 |
Alteration of theta timescale dynamics of hippocampal place cells by a cannabinoid is associated with memory impairment.
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoids; Choice Behavior; Cyclohexanols; Hippocampus; Memory Disorders; Motor Activity; Pyramidal Cells; Rats; Rats, Long-Evans; Running; Theta Rhythm | 2009 |
Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors.
Topics: Animals; Autoradiography; Body Weight; Brain; Cyclohexanols; Female; Male; Maze Learning; Memory Disorders; Nicotine; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Nicotinic; Sex Characteristics | 2011 |
[Effect of venlafaxine on cognitive function and hippocampal brain-derived neurotrophic factor expression in rats with post-stroke depression].
Topics: Animals; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Rats; Rats, Sprague-Dawley; Stroke; Venlafaxine Hydrochloride | 2011 |
Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats.
Topics: Aging; Animals; Anxiety; Behavior, Animal; Cannabinoids; Cognition; Conditioning, Operant; Cyclohexanols; Dronabinol; Exploratory Behavior; Female; Hallucinogens; Interpersonal Relations; Learning; Memory Disorders; Memory, Short-Term; Motor Activity; Psychomotor Performance; Rats; Rats, Wistar | 2004 |
Onset of confusion in the context of late-life depression.
Topics: Aged; Confusion; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Memory Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats.
Topics: Animals; Behavior, Animal; Cannabinoids; Cholinesterase Inhibitors; Cyclohexanols; Male; Maze Learning; Memory; Memory Disorders; Motor Activity; Physostigmine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant | 2000 |